Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers

Phase 2 Unknown 64 enrolled Anterogen Co., Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a phase 2 double-blind clinical study to evaluate the efficacy and Safety of ALLO-ASC-SHEET in subjects with Diabetic Wagner Grade II Foot Ulcers, compared to placebo therapy.

Timeline

Start: 2020-09-08
Primary completion: 2024-12
Completion: 2025-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ALLO-ASC-SHEET	Cell therapy	—	—

Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers

Summary

Timeline

Drugs

Indications